Gordon, K., Warren, R., Gottlieb, A., Blauvelt, A., Tha├ži, D., Poulin, Y., Boehnlein, M., Brock, F., Arendt, C., & Reich, K. (2020). Durable Efficacy of Certolizumab Pegol Dosed at 400 mg Every Two Weeks Over 128 Weeks in Patients with Plaque Psoriasis Enrolled in Three Phase 3 Trials (CIMPASI-1, CIMPASI-2, and CIMPACT). SKIN The Journal of Cutaneous Medicine, 4(6), s81. https://doi.org/10.25251/skin.4.supp.81